Circio Holding ASA (OL:CRNA) — Market Cap & Net Worth
Market Cap & Net Worth: Circio Holding ASA (CRNA)
Circio Holding ASA (OL:CRNA) has a market capitalization of $183.97 Million (Nkr1.75 Billion) as of June 17, 2026. Listed on the OL stock exchange, this Norway-based company holds position #16971 globally and #137 in its home market, demonstrating a -10.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Circio Holding ASA's stock price Nkr7.35 by its total outstanding shares 237867635 (237.87 Million). Review how much debt does Circio Holding ASA carry to assess the company's total debt and financial obligations.
Circio Holding ASA Market Cap History: 2015 to 2026
Circio Holding ASA's market capitalization history from 2015 to 2026. Data shows change from $8.64 Billion to $183.97 Million (-31.37% CAGR).
Circio Holding ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Circio Holding ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1465.20x
Circio Holding ASA's market cap is 1465.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $5.21 Billion | $624.00K | -$108.13 Million | 8345.70x | N/A |
| 2022 | $823.00 Million | $10.00 Million | -$432.90 Million | 82.28x | N/A |
| 2023 | $180.22 Million | $123.00K | -$112.94 Million | 1465.20x | N/A |
Competitor Companies of CRNA by Market Capitalization
Companies near Circio Holding ASA in the global market cap rankings as of June 17, 2026.
Key companies related to Circio Holding ASA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #442 globally with a market cap of $63.33 Billion USD.
- UCB SA (BR:UCB): Ranked #550 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #574 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $453.17 |
| #442 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.33 Billion | $614.73 |
| #550 | UCB SA | BR:UCB | $49.68 Billion | €250.00 |
| #574 | Argen-X | BR:ARGX | $47.14 Billion | €755.80 |
Circio Holding ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Circio Holding ASA's market cap moved from $8.64 Billion to $ 183.97 Million, with a yearly change of -31.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr183.97 Million | +531.44% |
| 2025 | Nkr29.14 Million | +63.94% |
| 2024 | Nkr17.77 Million | -90.14% |
| 2023 | Nkr180.22 Million | -78.10% |
| 2022 | Nkr823.00 Million | -50.41% |
| 2021 | Nkr1.66 Billion | -68.13% |
| 2020 | Nkr5.21 Billion | +10.50% |
| 2019 | Nkr4.71 Billion | +28.61% |
| 2018 | Nkr3.66 Billion | -57.89% |
| 2017 | Nkr8.70 Billion | +43.46% |
| 2016 | Nkr6.07 Billion | -29.81% |
| 2015 | Nkr8.64 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Circio Holding ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $183.97 Million USD |
| MoneyControl | $183.97 Million USD |
| MarketWatch | $183.97 Million USD |
| marketcap.company | $183.97 Million USD |
| Reuters | $183.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Circio Holding ASA
Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more